Analysis of Circulating Tumor DNA to Predict Risk of Recurrence in Patients With Esophageal and Gastric Cancers.
Brandon M HuffmanVasily N AushevGriffin L BuddeJoseph ChaoFarshid DayyaniDiana HannaGregory P BottaDaniel V T CatenacciSteven B MaronShifra KrinshpunShruti SharmaGiby V GeorgeMeenakshi MalhotraAdham JurdiSolomon MoshkevichAlexey AleshinPashtoon Murtaza KasiSamuel J KlempnerPublished in: JCO precision oncology (2022)
Using real-world data, we demonstrate that postoperative tumor-informed ctDNA detection in EGC is feasible and allows for enhanced patient risk stratification and prognostication during curative-intent therapy.
Keyphrases